These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31872690)

  • 1. [Pharmaceutics research advances in oral administration of puerarin].
    Wu WT; Zou B; Li WD; Zhu WF
    Zhongguo Zhong Yao Za Zhi; 2019 Oct; 44(19):4134-4141. PubMed ID: 31872690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Puerarin: a review of pharmacological effects.
    Zhou YX; Zhang H; Peng C
    Phytother Res; 2014 Jul; 28(7):961-75. PubMed ID: 24339367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry.
    Cui S; Zhao C; Tang X; Chen D; He Z
    Biomed Chromatogr; 2005 Jun; 19(5):375-8. PubMed ID: 15627278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine.
    Zhang L
    Drug Deliv; 2019 Dec; 26(1):860-869. PubMed ID: 31524010
    [No Abstract]   [Full Text] [Related]  

  • 5. Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone.
    Cui S; Zhao C; Chen D; He Z
    Drug Dev Ind Pharm; 2005 May; 31(4-5):349-56. PubMed ID: 16093200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Methods of Puerarin Biotransformation.
    Liu G; Liu Z; Yuan S
    Mini Rev Med Chem; 2016; 16(17):1392-1402. PubMed ID: 27145856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Pharmacokinetic Profiles of Puerarin in Rat Plasma by UHPLC-MS/MS after Oral Administration of
    Zhang G; Ji J; Sun M; Ji Y; Ji H
    J Anal Methods Chem; 2020; 2020():4258156. PubMed ID: 32351754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Puerarin-an isoflavone with beneficial effects on bone health.
    Kulczyński B; Gramza-Michałowska A; Suliburska J; Sidor A
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1653-1667. PubMed ID: 34994179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations.
    Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata.
    Chen X; Yu J; Shi J
    Am J Chin Med; 2018; 46(8):1771-1789. PubMed ID: 30525896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of multicomponent environment on intestinal permeability of puerarin in biopharmaceutics classification system of Chinese materia medica].
    Liu Y; Wang G; Dong L; Tang MM; Zhu ML; Dong HH; Hou CB
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4505-8. PubMed ID: 25911791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of the C-glucosylation for puerarin biosynthesis in Pueraria lobata.
    Wang X; Li C; Zhou C; Li J; Zhang Y
    Plant J; 2017 May; 90(3):535-546. PubMed ID: 28207970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats.
    Li H; Dong L; Liu Y; Wang G; Wang G; Qiao Y
    Int J Pharm; 2014 May; 466(1-2):133-8. PubMed ID: 24607203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Extraction, Purification, and Analysis Techniques of the Main Components of Kudzu Root: A Comprehensive Review.
    Xuan T; Liu Y; Liu R; Liu S; Han J; Bai X; Wu J; Fan R
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Pharmacokinetics of Puerarin Alone and in Pueraria mirifica Extract in Female Cynomolgus Monkeys.
    Namken S; Songvut P; Nuengchamnong N; Kemthong T; Khemawoot P; Malaivijitnond S
    Planta Med; 2021 Apr; 87(5):395-403. PubMed ID: 33063303
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics of pueraria for intranasal on spray in rabbits].
    Lu Y; Zhang T; Tao JS; Xu LY
    Zhong Yao Cai; 2007 Sep; 30(9):1102-5. PubMed ID: 18236755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of UDP-glucuronosyltransferase 1a1, 1a7 and P-glycoprotein expression in hepatic fibrosis rats and the impact on pharmacokinetics of puerarin.
    Zhang MF; Liu YX; Jiang KY; Niu HM; Jiang JL; Dong ST; Wang X; Wang DF; Meng SN
    Phytomedicine; 2019 Jan; 52():264-271. PubMed ID: 30599907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of puerarin against cerebral diseases: From bench to bedside.
    Liu T; Su K; Cai W; Ao H; Li M
    Eur J Pharmacol; 2023 Aug; 953():175695. PubMed ID: 36977450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.